It is a dosage form administered subcutaneously for the treatment of relapsing forms of multiple sclerosis in adults.
The global market for Ofatumumab is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Ofatumumab market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Ofatumumab market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Ofatumumab market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Ofatumumab market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Ofatumumab players cover Glaxosmithkline Inc and Novartis.. etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Ofatumumab market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Ofatumumab market, with both quantitative and qualitative data, to help readers understand how the Ofatumumab market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Ofatumumab market and forecasts the market size by Type (20mg/1mL, 20mg/0.4mL and 100mg/5mL), by Application (Relapsing-remitting Multiple Sclerosis, Clinically Isolated Syndrome, Active Secondary Progressive Multiple Sclerosis and Others), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
20mg/1mL
20mg/0.4mL
100mg/5mL
Others
Segmentation by application
Relapsing-remitting Multiple Sclerosis
Clinically Isolated Syndrome
Active Secondary Progressive Multiple Sclerosis
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Glaxosmithkline Inc
Novartis
Chapter Introduction
Chapter 1: Scope of Ofatumumab, Research Methodology, etc.
Chapter 2: Executive Summary, global Ofatumumab market size (sales and revenue) and CAGR, Ofatumumab market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Ofatumumab sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Ofatumumab sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Ofatumumab market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Glaxosmithkline Inc and Novartis etc.
Chapter 14: Research Findings and Conclusion